Porcine Vaccines Market Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Albany, USA, 2018-Dec-20 — /EPR Network/ —This report on the Porcine Vaccines Market analyzes the current and future scenario of the global market. Increase in the prevalence of diseases among swine, technological advancements of RNA strand methodology, and cultivation of pigs to raise standards of living are likely to drive the global porcine vaccines market during the forecast period. Increase in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the factors expected to drive the global porcine vaccines market during the forecast period.

Free | Request Sample Report Copy, Click here @ https://www.mrrse.com/sample/4770

This report on the global porcine vaccines market comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the market with respect to segments based on disease indication, technology, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porter’s five forces analysis to help understand the competition landscape of the market. This section also provides market attractiveness analysis, in terms of country, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competition scenario in the global porcine vaccines market.

Based on technology, the porcine vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. These market segments have been extensively analyzed based on increase in the demand for treatment of diseases such as PED, PRRS, and PCVAD. Surging demand for disease-free pork meat and increasing awareness for treating cultivated pigs are driving the technology segments of the market. Different types of end-users utilize porcine vaccines to treat swine diseases. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospitals segment. The market size (in terms of US$ Mn) and forecast for each segment have been provided for the period from 2015 to 2025. The report also provides the compounded annual growth rate (CAGR %) for each segment for the period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others. Diarrhoea is the most widespread disease among pigs across the world. Porcine epidemic diarrhea virus (PEDV) hit the U.S. in 2013 and spread to Canada in 2014, which infected piglets. It had 80%–100% mortality rate. The above-mentioned segments have been analyzed based on available approved products, their cost-effectiveness, and preference by veterinarians for treating swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global porcine vaccines market has been categorized into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in the market in these regions.

Browse Full Report with TOC @ https://www.mrrse.com/porcine-vaccines-market

The report also profiles major players in the global porcine vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report are Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Vetoquinol, and Zoetis Inc.

The global porcine vaccines market has been segmented as below:

Global Porcine Vaccines Market, by Disease Indication, 2015–2025

• Diarrhea
• Swine Influenza
• Arthritis
• Bordetella Rhinitis
• Porcine Reproductive and Respiratory Syndrome (PRRS)
• Porcine Circovirus Associated Disease (PCVAD)
• Others (CHRS, Leptospirosis, etc.)

Global Porcine Vaccines Market, by Technology, 2015–2025

• Inactivated Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Conjugate Vaccines
• DNA Vaccines

Global Porcine Vaccines Market, by End-user, 2015–2025

• Veterinary Hospitals
• Hog Production Farms

Global Porcine Vaccines Market, by Geography, 2015–2025

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Rest of Middle East & Africa

Enquiry Now @ https://www.mrrse.com/enquiry/4770

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY – 12207(United State)
Telephone: +1-518-730-0559(USA & Canada Toll-Free)
Email: sales@mrrse.com
Website: https://www.mrrse.com/